Obeticholic acid - Intercept Pharmaceuticals
At a glance
- Drug Originator GlaxoSmithKline; Universita degli Studi di Perugia
- Drug Licenced by ADVANZ PHARMA
- Drug Class Anti-inflammatories; Antifibrotics; Antihyperglycaemics; Antihypertensives; Cholic acids; Cyclopentanes; Gallstone therapies; Hepatoprotectants; Obesity therapies; Pentanoic acids; Phenanthrenes; Small molecules
- Mechanism of Action Farnesoid X-activated receptor agonists
- USA Patent Applicants INTERCEPT PHARMS INC
- USA Patents 21
- NDAs 1
- International Patents 123
- Patent Applications 531
Table of Contents
Disclaimer